Clinical Trials in Pittsburgh

Showing 13281-13300 of 21,047 trials

Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer

NCT01239342

This randomized phase II trial studies the side effects and how well Akt inhibitor MK2206 or everolimus works in treating patients with kidney cancer that does not respond to treatment. Akt inhibitor MK2206 and everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Everolimus may also stop the growth of kidney cancer by blocking blood flow to the tumor. It is not yet known whether Akt inhibitor MK2206 or everolimus is more effective in treating kidney cancer.

Metastatic Kidney CarcinomaRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+1 more

National Cancer Institute (NCI)43 participantsStarted Jan 2011

Beverly Hills, California, United States • Duarte, California, United States • Los Angeles, California, United States +5 more locations

TERMINATEDPhase 3< 1 mile

Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo

NCT01900665

To test the idea that solanezumab will slow the cognitive decline of Alzheimer's Disease (AD) as compared with placebo in participants with mild AD.

Alzheimer's Disease

Eli Lilly and Company2,129 participantsStarted Jul 2013

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +195 more locations

Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer

Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo

Find Trials by Condition in Pittsburgh

ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation

Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers

Evaluation of an Online Intervention to Help LGBTQ Youth Cope With Bullying

Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease

A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease

Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis

A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis

Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer

THA Kinematics and Sound for Subjects Implanted Using Various Surgical Approaches

A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)

Evaluating Progression of and Diagnostic Tools for Primary Ciliary Dyskinesia in Children and Adolescents

Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia

Abbott Laboratories Alinity s Blood Screening Assays - Clinical Evaluation Protocol

A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes

e-NOBORI Observational Registry of Nobori DES